Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2- HIV Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00025727
What this trial is testing

Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure

Who this might be right for
HIV Infections
GlaxoSmithKline 330
Testing effectiveness (Phase 2)Study completedNCT00000789
What this trial is testing

A Randomized, Comparative Trial of Zidovudine (AZT) Versus 2',3'-Didehydro-3'-Deoxythymidine (Stavudine; d4T) in Children With HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 230
Large-scale testing (Phase 3)Study completedNCT00543725
What this trial is testing

TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors

Who this might be right for
HIV InfectionsHIV-1
Tibotec Pharmaceuticals, Ireland 680
Not applicableEnded earlyNCT02898896
What this trial is testing

Coronary Artery Disease (CAD) in Suppressed HIV-infected

Who this might be right for
Virus-HIV
University Hospital, Montpellier 62
Not applicableActive Not RecruitingNCT06773754
What this trial is testing

Fixed-Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide Taken as 5 Days Per Week

Who this might be right for
Virally Suppressed People With HIV
National Taiwan University Hospital 60
Not applicableStudy completedNCT01447680
What this trial is testing

Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing

Who this might be right for
Human Immunodeficiency Virus InfectionHepatitis C
G & W Laboratories Inc. 1,600
Post-approval studies (Phase 4)Not Yet RecruitingNCT07631897
What this trial is testing

Comparative Trial Between Ainuovirine(ANV)/Lamivudine(3TC)/Tenofovir(TDF) and Efavirenz(EFV)/Lamivudine/Tenofovir Regimens

Who this might be right for
HIVArt TherapyTB - Tuberculosis
Shanghai Public Health Clinical Center 60
Testing effectiveness (Phase 2)Study completedNCT03851588
What this trial is testing

Standard Versus Double Dose Dolutegravir in Patients With HIV-associated Tuberculosis

Who this might be right for
HIV InfectionsTuberculosis
University of Cape Town 108
Not applicableStudy completedNCT01437241
What this trial is testing

Etravirine Plus 2 Analogs in HIV-infected Patients

Who this might be right for
HIV-1-infection
Hospitales Universitarios Virgen del Rocío 175
Early research (Phase 1)Study completedNCT00002360
What this trial is testing

A Study Comparing Two Forms of Didanosine in HIV-infected Patients

Who this might be right for
HIV Infections
Bristol-Myers Squibb 30
Not applicableEnrolling By InvitationNCT07279376
What this trial is testing

Evaluating an Algorithm-Based Implementation Strategy to Improve HIV Care Outcomes

Who this might be right for
HIV (Human Immunodeficiency Virus)
Hunter College of City University of New York 2,600
Large-scale testing (Phase 3)UnknownNCT00008489
What this trial is testing

Comparing Side Effects of Two Forms of Videx in HIV-Infected Adults

Who this might be right for
HIV Infections
PharmaResearch 200
Not applicableStudy completedNCT00636220
What this trial is testing

Evaluation of the DPP HIV 1/2 Test and the HIV 1/2 Stat Pak Test Using Oral Fluid

Who this might be right for
HIV Infections
Chembio Diagnostic Systems, Inc. 101
Post-approval studies (Phase 4)Study completedNCT00885482
What this trial is testing

Atazanavir and Lamivudine for Treatment Simplification

Who this might be right for
HIV Infections
Catholic University of the Sacred Heart 40
Testing effectiveness (Phase 2)Study completedNCT03603808
What this trial is testing

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

Who this might be right for
Anal Intraepithelial NeoplasiaHigh Grade Squamous Intraepithelial NeoplasiaHIV Positivity+2 more
AIDS Malignancy Consortium 44
Large-scale testing (Phase 3)Study completedNCT01011413
What this trial is testing

Safety and Efficacy of Reduced Versus Standard Dose Efavirenz (EFV) Plus Two Nucleotides in Antiretroviral-naïve Adults.

Who this might be right for
HIV Infections
Kirby Institute 636
Not applicableUnknownNCT02674867
What this trial is testing

CLEAC (Comparison of Late Versus Early Antiretroviral Therapy in HIV-infected Children)

Who this might be right for
HIV Infection
ANRS, Emerging Infectious Diseases 80
Early research (Phase 1)WithdrawnNCT00000809
What this trial is testing

Safety and Effectiveness of Two Different Formulations of an HIV Vaccine in Infants Born to HIV-Infected Women

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Study completedNCT00574600
What this trial is testing

Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48
Not applicableStudy completedNCT01922206
What this trial is testing

Maternal HIV: Trial to Assist Disclosure to Children

Who this might be right for
HIV
Georgia State University 362
Next Page